Aerie Pharmaceuticals (United States)
Aerie Pharmaceuticals was an American clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Aerie Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
55%
Total
Publications
64
Total Open
Publications
35
Total
Citations
3.2K
Open Access
Percentage
55%
Total
Publications
64
Total Open
Publications
35
Total
Citations
3.2K
Breakdown
Publisher Open
16%
Both
29%
Other Platform Open
8%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
7
Hybrid 54%
15
No Guarantees 21%
6
Other Platform Open
Domain 87%
20
Other Internet 17%
4
Institution 9%
2
Public 4%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 20 |
DOI | Other Internet | 3 |
Imperial College London - Spiral | Institution | 2 |
Unknown Repository | Other Internet | 1 |
Figshare | Public | 1 |
Europe PMC | Domain | 1 |